SGLT2 Inhibitors vs Sitagliptin in Patients With Heart Failure and Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Heart Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
Eur Heart J 2023 Jun 01;[EPub Ahead of Print], EL Fu, E Patorno, BM Everett, M Vaduganathan, SD Solomon, R Levin, S Schneeweiss, RJ DesaiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.